In AD, the presence of β-amyloid plaques causes CX3CL1 to no longer bind its receptor; this causes hyperactivation of the microglia with consequent activation of p38, which has been seen to have increased its expression in the early stages of AD. Here, CX3CL1 is linked to Alzheimer disease.